Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)

NCT: NCT07741656 · RECRUITING

NCT IDNCT07741656
StatusRECRUITING
Start Date2025-09-26
Completion2027-01-31
SponsorAndromeda Surgical (INDUSTRY)
First posted
Last updated

Brief Summary

This single-arm study aims to evaluate the Beacon Platform, an advancement in urological surgery. The study will assess its intraoperative and postoperative outcomes. The aim of this investigation is to establish safety and performance of the Beacon Platform.

Frequently Asked Questions

What is A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)?

A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP) is a clinical trial registered under NCT07741656. Current status: RECRUITING.

What is the status of NCT07741656?

The current status of NCT07741656 (A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP)) is: RECRUITING.

When did A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP) start?

A Study of the Beacon Platform for Holmium Laser Enucleation of the Prostate (HoLEP) started on 2025-09-26.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.